๐Ÿ“–
Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.
Daneshyar S, Ghiasian M, Khazaei S, Alborzi K, Ebadi M

Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Caspian J Intern Med.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Disease-modifying therapies (DMTs) discontinuation in older relapsing-remitting multiple sclerosis (RRMS) patients with stable disease: Two-year randomized, controlled trial.
Author / Organization Daneshyar S, Ghiasian M, Khazaei S, Alborzi K, Ebadi M
Subject & Discipline Caspian J Intern Med
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-48239
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »